Jyothy Labs share news, announcements and annual reports
NSE: JYOTHYLABBSE: 532926Household ProductsSmall Cap
Jyothy Labs Limited · Formerly Jyothy Laboratories · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2007
Last close ₹171.91down ₹3.15 (1.80%)BSE ₹172.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹175.06.
30 Oct: open ₹174.45, high ₹175.10, low ₹171.00
52-week range of traded prices to 30 Oct 2026
₹171.00Low, 30 Oct 2026₹322.75High, 30 Oct 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and buyback. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,313 Cr603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,85,76453.8% delivered
Jyothy Labs shareholding disclosures
44 filed, newest first.
Oct 2026
5 Oct · Disclosure
Apr 2026
Nov 2025
Apr 2025
Mar 2025
Jan 2025
7 Jan · Disclosure
Sep 2024
4 Sep · Disclosure
Apr 2024
Sep 2023
4 Sep · Disclosure
Apr 2023
Jun 2022
Apr 2022
Apr 2021
May 2020
Apr 2019
Nov 2018
16 Nov · Disclosure
Apr 2018
Nov 2017
21 Nov · Disclosure
7 Nov · Disclosure
Sep 2017
8 Sep · Disclosure
Apr 2017
Jan 2017
24 Jan · Disclosure
Oct 2016
Sep 2016
Apr 2016
Mar 2016
Apr 2015
Jan 2015
Dec 2014
Nov 2014
Aug 2014
28 Aug · Disclosure
Remuneration and Compensation Committee of the Board of Directors of the Company at its meeting held on August 16, 2014 has approved the grant of 5,03,445 Stock Options to eligible employees of the Company, in terms of Employee Stock Option Scheme 2014 ("ESOS-2014"). The said options carry the right to apply for equivalent number of equity shares of the Company of face value of Re. 1/- each, the brief terms of which are as under: 1. Vesting : The options shall vest over a period of 4 years on the basis of time and performance. 2. exercise period 5 years from the date of vesting of options. 3. Exercise price Re. 1/- per share for 5,03,445 of stock options.28 Aug · Disclosure
Remuneration and Compensation Committee of the Board of Directors of the Company at its meeting held on August 16, 2014 has approved the grant of 27,15,325 Stock Options to Mr.S Raghunandan, Whole Time Director and CEO of the Company, in terms of Employee Stock Option Scheme 2014-A ("ESOS-2014-A"). The said options carry the right to apply for equivalent number of equity shares of the Company of face value of Re. 1/- each, the brief terms of which are as under: 1. Vesting : The options shall vest over a period of 4 years on the basis of time and performance. 2. exercise period 5 years from the date of vesting of options. 3. Exercise price Re. 1/- per share for 27,15,352 of stock options.
Mar 2014
Dec 2013
Aug 2012
Dec 2011
14 Dec · Disclosure